Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease

Stroke

Volumn 38, Issue 8, 2007, Pages 2391-2396

  Fiorella, David ^a   Woo, Henry H ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Angioplasty; Drug eluting stent; Intracranial atherosclerosis; Stent; Wingspan stent

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ARTERY THROMBOSIS; BRAIN ATHEROSCLEROSIS; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; HUMAN; INTERMETHOD COMPARISON; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK REDUCTION; STROKE; TREATMENT INDICATION; ANGIOPLASTY; BRAIN ARTERY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; INSTRUMENTATION; METHODOLOGY; NEUROSURGERY; STANDARD; STATISTICS; STENT; TREATMENT OUTCOME;

ANGIOPLASTY; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; NEUROSURGERY; STENTS; TREATMENT OUTCOME;

EID: 34548263668     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.482752     Document Type: Review

References (49)

1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
2. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ. Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.
3. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915-924.
4. Zaidat OO, Alexander MJ, Suarez JI, Tarr RW, Selman WR, Enterline DS, Smith TP. Early carotid artery stenting and angioplasty in patients with acute ischemic stroke. Neurosurgery. 2004;55:1237-1242.
5. Anonymous. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med. 1985;313:1191-1200.
6. Hopkins LN, Budny JL. Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg. 1989;70:207-211.
7. Sundt TM Jr, Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clinic Proc. 1980;55:673-680.
8. Higashida RT, Tsai FY, Halbach VV, Dowd CF, Smith T, Fraser K, Hieshima GB. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg. 1993;78:192-198.
9. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. Am J Neuroradiol. 1998;19:1525-1533.
10. Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology. 1997;39:111-116.
11. Clark WM, Barnwell SL, Nesbit G, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke. 1995;26:1200-1204.
12. Gress DR, Smith WS, Dowd CF, Van Halbach V, Finley RJ, Higashida RT. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery. 2002;51:23-27.
13. Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg. 1999;91:415-423.
14. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, Do HM. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke. 2006;37:1016-1020.
15. Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors JJ 3rd. Intracranial angioplasty and stenting: long-term results from a single center. Am J Neurorad. 2006;27:1882-1892.
16. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. Am J Neuroradiology. 2005;26:525-530.
17. Terada T, Higashida RT, Halbach VV, Dowd CF, Nakai E, Yokote H, Itakura T, Hieshima GB. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatr. 1996;60:377-381.
18. Nahser HC, Henkes H, Weber W, Berg-Dammer E, Yousry TA, Kuhne D. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. Am J Neurorad. 2000;21:1293-1301.
19. Kiyosue H, Okahara M, Yamashita M, Nagatomi H, Nakamura N, Mori H. Endovascular stenting for restenosis of the intracranial vertebrobasilar artery after balloon angioplasty: two case reports and review of the literature. Cardiovasc Interventional Radiol. 2004;27:538-543.
20. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489-495.
21. Savage MP, Fischman DL, Rake R, Leon MB, Schatz RA, Penn I, Nobuyoshi M, Moses J, Hirshfeld J, Heuser R, Baim D, Cleman M, Brinker J, Gebhardt S, Goldberg S. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study (STRESS) Investigators. J Am Coll Cardiol. 1998;31:307-311.
22. George CJ, Baim DS, Brinker JA, Fischman DL, Goldberg S, Holubkov R, Kennard ED, Veltri L, Detre KM. One-year follow-up of the Stent Restenosis (STRESS I) Study. Am J Cardiol. 1998;81:860-865.
23. Feldman RL, Trigg L, Gaudier J, Galat J. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of an intracranial carotid artery stenosis. Cath Cardiovasc Diagn. 1996;38:316-319.
24. Gomez CR, Misra VK, Campbell MS, Soto RD. Elective stenting of symptomatic middle cerebral artery stenosis. [Case Reports. Journal Article] Am J Neuroradiology. 2000;21:971-973.
25. Yu W, Smith WS, Singh V, Ko NU, Cullen SP, Dowd CF, Halbach VV, Higashida RT. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology. 2005;64:1055-1057.
26. Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. Am J Neuroradiol. 2005;26:869-874.
27. Levy EI, Horowitz MB, Koebbe CJ, Jungreis CC, Pride GL, Dutton K, Purdy PD. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery. 2001;48:1215-1221.
28. Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke. 2004;35:1375-1380.
29. Kim JK, Ahn JY, Lee BH, Chung YS, Chung SS, Kim OJ, Kim WC, Joo JY. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatr. 2004;75:847-851.
30. Levy EI, Hanel RA, Bendok BR, Boulos AS, Hartney ML, Guterman LR, Qureshi AI, Hopkins LN. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg. 2002;97:1294-1301.
31. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology. 2007;68:420-426.
32. Henkes H, Bose A, Felber S, Miloslavski E, Berg-Dammer E, Kuhne D. Endovascular coil occlusion of intracranial aneurysms assisted by a novel self-expandable Nitinol microstent (Neuroform). Interventional Neuroradiology. 2002;8:107-119.
33. Fiorella D, Albuquerque FC, Deshmukh VR, McDougall CG. Usefulness of the Neuroform stent for the treatment of cerebral aneurysms: results at initial (3-6-mo) follow-up. Neurosurgery. 2005;56:1191-1201.
34. Hahnel S, Ringleb P, Hartmann M. Treatment of intracranial stenoses using the Neuroform stent system: initial experience in five cases. Neuroradiology. 2006;48:479-485.
35. European HDE study. Presented at the American Society of Neuroradiology 43rd Annual Meeting, Toronto, Canada, May 23-27, 2005.
36. Albuquerque FC. (on behalf of the Multicenter Neuroendovascular Research Collaboration.) US Wingspan Registry: Results at 1 year. Presented at the 2007 International Stroke Conference, San Francisco, CA, February 7-9, 2007.
37. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kuhne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology. 2005;47:222-228.
38. Fiorella D, Levy EI, Turk A, Albuquerque FC, Niemann DB, Aagaard-Lienitz B, Hanel RA, Woo HH, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke. 2007;38:881-887.
39. Bose A. The Wingspan Study. Presented at the American Society of Neuroradiology 43rd Annual Meeting, Toronto, Canada, May 23-27, 2005.
40. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med. 2006;354:483-495.
41. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37:2562-2566.
42. Qureshi AI, Kirmani JF, Hussein HM, Harris-Lane P, Divani AA, Suri MF, Janjua N, Alkawi A. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59:1044-1051.
43. Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke. 2005;36:e165-e168.
44. Levy EI, Hanel RA, Tio FO, Garlick DS, Bailey L, Cunningham MR, Williard C, Sherman D, Dooley JF, Kopia GA. Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 day assessment. Neurosurgery. 2006;59:925-933.
45. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48:2584-2591.
46. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119:1056-1061.
47. Otsuka Y, Chronos NA, Apkarian R, Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher Stents. J Invasive Cardiol. 2007;19:71-76.
48. Daemen J, Tsuchida K, Abrecht L, Sophia V, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, Domburg Van RT, Hess OM, Boersma E, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus eluting and paclitaxel eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet. 2007;369:667-678.
49. Rogers CD. Drug Eluting Stents: Clinical perspectives on drug and design differences. Rev Cardiovasc Med. 2005;6 (suppl 1):S13-S21.